alexa Developing Lead Compounds That Restore Death Sensitivity To Trophic Withdrawal In MYCN-initiated Death Resistant Cells
ISSN: 2161-1459

Journal of Clinical & Experimental Pharmacology
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

8th World Congress on Pharmacology and Toxicology
July 24-25, 2017 Melbourne, Australia

Belamy B Cheung, Owen Tan, Jessica Koach, Selina Sutton, Sonya M Diakiw, Carol G Au, Kacper Jankowski, Toby N Trahair, Shizhen Zhu, Daniel R Carter and Glenn M Marshall
UNSW Lowy Cancer Research Centre, Australia
Biochemistry and Molecular Biology Centre, USA
Kids Cancer Centre, Australia
ScientificTracks Abstracts: Clin Exp Pharmacol
DOI: 10.4172/2161-1459-C1-019
Abstract
Embryonic cancer arises from postnatal persistent embryonal remnant or rest cells that are uniquely characterized by the absence of p53 mutations. We have showed that c-Myc and Myc N-overexpressing perinatal murine pre-B lymphocytes are resistant to apoptosis induced by interleukin-7 (IL-7) withdrawal and are associated with decreased p53 induction. From an initial library of 40,000 compounds, we generated a list of 56 hit compounds that displayed activity against Myc N-expressing pre-B cells in the absence of IL-7, but had minimal effect on cells in the presence of trophic factor. One of the lead compound, PB-798, reduced ganglia cell growth only in the absence of NGF and restored sensitivity to NGF withdrawal-induced cell death in myc N-expressing ganglia cells from TH-myc N homozygous mice, suggest that PB-798 can restore death sensitivity to trophic withdrawal in Myc-driven persistent rest cells. Furthermore, we investigated the potential mechanisms of cell death initiated by PB-798. By western blot, we found PB-798 treatment after 72 hours at 10 μM significantly reduced myc N protein levels in myc N-expressing clone F cells. We performed Affymetrix gene arrays and nanostring analysis to investigate the key genes/signaling pathways involved in the mechanism of cell death. We found that seven signaling pathways were significantly enriched. We have now identified 7 target genes in steroid biosynthesis and 5 target genes in JAK/STAT signaling pathways as the potential molecular targets for PB-798 drug action. Importantly, we have tested the efficacy of PB-798 in Myc N over-expression zebrafish neuroblastoma model and found that PB-798 significantly inhibits myc N-induced neuroblastic hyperplasia in the inter-renal gland (IRG) of this Myc N over-expression zebrafish model. PB-798 will be further tested in in vivo models of myc-driven tumor initiation such as the Eμ-Myc mouse model of lymphoma and the TH-myc N neuroblastoma mouse model.
Biography

Belamy B Cheung was graduated from Sun Yat-sen University of Medical Science, Guangzhou, China and obtained her PhD degree at University of New South Wales, Australia. Presently, she is the Manager and Project Leader of the Molecular Carcinogenesis Program at Children's Cancer Institute Australia. Her research is currently focusing on drug discovery leading to the identification of small molecule inhibitors of oncogene targets. Most of her publications are in highly ranked journals, including Nature Reviews Cancer (IF37.9), Science Translational Medicine (IF15.8), Oncogene (IF 8.5) and Journal of the National Cancer Institute (IF14.3).

Email: [email protected]

image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords